Stock Market News 24 December 2025

Salesforce (CRM) Stock News Today: Agentforce Momentum, AI Reliability Questions, and Updated Wall Street Forecasts (Dec. 24, 2025)

Salesforce, Inc. (NYSE: CRM) stock is closing out 2025 with two narratives battling for investor attention: accelerating traction in its Agentforce and Data 360 products, and a growing industry debate about how reliably large language models (LLMs) can “run the business” without guardrails. On December 24, 2025, Salesforce shares traded around $266 and were modestly higher on the day, but the stock remains down roughly ~21% year-to-date after a volatile year that saw the shares swing from a 52-week high of $367.09 (Jan. 28, 2025) to a 52-week low of $221.96 (Nov. 21, 2025). FinanceCharts+1 Below is what’s driving the

24 December 2025

NYSE:CRM·Salesforce News·Stock Market

Wave Life Sciences (WVE) Stock: December 24, 2025 News Roundup, Analyst Forecasts, and What Investors Are Watching Next

Wave Life Sciences Ltd. (NASDAQ: WVE) is ending 2025 as one of biotech’s most watched “story stocks”—the kind that can go from sleepy to screaming in a single premarket headline, then spend weeks digesting what just happened. On December 24, 2025, Wave shares traded in the high teens (around ~$18), still hovering near the re-rated levels that followed its early obesity readout and a sizable capital raise earlier this month. Multiple market data sources showed WVE around $18.1–$18.5 intraday, with the day’s range roughly $17.49 to ~$18.5. StockAnalysis+2Investing.com Australia+2 Below is a consolidated, publication-ready look at the most relevant WVE

24 December 2025

Biotechnology·Stock Market

Intel Stock INTC Slips as Nvidia Pauses 18A Test: Latest News, Forecasts, and What Matters Next

Intel Corporation stock (NASDAQ: INTC) traded lower on Wednesday, December 24, 2025, as investors digested a fresh headline that strikes at the heart of Intel’s turnaround narrative: whether its next-generation manufacturing technology is ready to win — and keep — the world’s biggest chip designers. INTC was last around $35.97, down about 1% on the day, after swinging between $34.48 and $36.49 in a holiday-thinned session. The timing matters. Christmas Eve trading in the U.S. was shortened, volumes were lighter than usual, and the broader market tone was relatively calm — even upbeat — with the S&P 500 touching an

24 December 2025

NASDAQ:INTC·Stock Market

Travere Therapeutics (TVTX) Stock Jumps on Dec. 24, 2025: 52-Week High, FDA Catalyst Ahead, and Analyst Price Targets

Travere Therapeutics, Inc. (NASDAQ: TVTX) is ending 2025 with a bang. In the holiday-shortened U.S. trading session on Wednesday, December 24, 2025, TVTX surged sharply—pushing to fresh highs as investors recalibrated around two big themes: accelerating commercial execution for FILSPARI (sparsentan) and a looming FDA decision that could expand the drug into a second major kidney disease indication. StockAnalysis+2New York Stock Exchange+2 TVTX stock action on Dec. 24, 2025: a thin-session breakout with big numbers In early trading on Dec. 24, TVTX was up roughly 15% and changing hands around the low $40 range—an outsized move for a single session,

24 December 2025

NASDAQ:TVTX·Stock Market

UiPath (PATH) Stock Jumps on S&P MidCap 400 Addition: Price Move, Analyst Targets, and What to Watch Next

NEW YORK — December 24, 2025 — UiPath Inc. (NYSE: PATH) is having a headline-grabbing Christmas Eve session, with shares climbing sharply after S&P Dow Jones Indices selected UiPath for inclusion in the S&P MidCap 400. In late-morning U.S. trading, PATH hovered around $17.25, up roughly 8% on the day, after opening higher and trading between roughly $16.70 and $17.36. StockAnalysis The move is landing during a holiday-shortened session (U.S. equities close early on Christmas Eve), which can magnify price swings as liquidity thins out. Investopedia UiPath stock price today: what the market is reacting to The catalyst isn’t a

24 December 2025

NYSE:PATH·Stock Market

Nike Stock (NKE) Jumps on Tim Cook’s $3M Share Buy as Turnaround Pressures Mount: News, Forecasts and Analysis for Dec. 24, 2025

Nike, Inc. (NYSE: NKE) stock is getting a rare kind of holiday-season lift: a high-profile insider purchase. In the holiday-shortened U.S. trading session on Wednesday, December 24, 2025, shares climbed roughly 4%–5% after filings showed Apple CEO Tim Cook—also Nike’s long-time board member and lead independent director—bought about $3 million worth of Nike shares on the open market. Reuters+1 The move arrives at a sensitive moment for investors. Nike shares had fallen sharply after the company’s latest quarterly results and guidance, as management works through a wide-ranging reset under CEO Elliott Hill. Cook’s purchase doesn’t erase the fundamentals overnight—but it

24 December 2025

Nike·NYSE:NKE·Stock Market

Home Depot Stock (HD) News Today, Dec. 24, 2025: Price Action, Analyst Forecasts, and What Investors Are Watching

Home Depot, Inc. (NYSE: HD) is trading through a shortened Christmas Eve session with investors juggling mixed signals: upbeat Wall Street ratings, cautious earnings-revision trends, and a steady drumbeat of institutional-position headlines. Meanwhile, the broader market’s “Santa rally” narrative is picking up steam as the S&P 500 notched a fresh record intraday high on Wednesday. Reuters+1 As of the latest available trade on December 24, 2025, HD shares were around $347.51, up roughly 0.7% on the day, after opening near $344 and trading in the mid-$340s range. MarketWatch Below is a complete roundup of the key HD stock news, forecasts,

24 December 2025

NYSE:HD·Stock Market

Procter & Gamble (PG) Stock Today: Analyst Upgrades, Tariff Pressures, and a CEO Change Set the Tone for 2026

December 24, 2025 — Procter & Gamble (NYSE: PG) is ending 2025 in a familiar role for markets: a defensive bellwether that investors watch closely for clues about consumer demand, pricing power, and how quickly households are trading down—or trading up—when the economy gets choppy. On December 24, 2025, with U.S. markets operating in a holiday-shortened session and broad indexes still hovering near record territory, P&G stock is trying to stabilize after a rough stretch that pushed shares toward early-December lows. Investopedia+1 Below is what’s moving Procter & Gamble stock right now, what Wall Street is forecasting, and the specific

24 December 2025

NYSE:PG·Stock Market

Polestar Stock (PSNY) Surges on Fresh Funding: Latest News, Analyst Forecasts, and What Investors Are Watching (Dec. 24, 2025)

Polestar Automotive Holding UK PLC (Nasdaq: PSNY) is back in the market spotlight on December 24, 2025, with the stock rallying sharply as investors digest a string of balance-sheet moves designed to extend liquidity, reduce leverage, and keep the company’s Nasdaq listing in good standing. Business Wire+2Reuters+2 The quick version: PSNY traded around $17.09, up roughly 13% on the day, after Polestar announced $300 million in new equity, a plan for ~$300 million of debt to convert into equity, and a Geely-backed term loan facility of up to $600 million. Those are big numbers for a company that has been

24 December 2025

Electric Vehicles·NASDAQ:PSNY·Stock Market

Merck Stock Forecast and News Roundup for December 24, 2025: MRK Hits a New 52-Week High as Wall Street Reprices 2026 Catalysts

Merck & Company, Inc. stock is ending 2025 on a strong note. On December 24, 2025, shares of Merck (MRK) pushed to a fresh 12‑month high around the $106 level, extending a powerful late‑year rally that has put the pharma bellwether back in the spotlight. MarketBeat+2Investing.com+2 This move isn’t happening in a vacuum. Today’s MRK price action sits at the intersection of three market themes that have dominated Merck headlines into Christmas Eve: Below is a comprehensive, publication-ready roundup of the current news, forecasts, and analysis investors are reading as of December 24, 2025, and what it could mean for

24 December 2025

NYSE:MRK·Pharmaceuticals·Stock Market

Edgewise Therapeutics Stock (EWTX) Jumps on EDG-7500 CIRRUS-HCM Update: Dec. 24, 2025 News, Analyst Forecasts, and Key Catalysts

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) stock surged in intraday trading on Wednesday, December 24, 2025, after the company released a fresh update on EDG-7500, its investigational therapy for hypertrophic cardiomyopathy (HCM). By late morning, shares were trading around $26.37—up roughly 21% versus the prior close—after swinging between about $21.30 and $27.05 on the day, with volume above 2.2 million shares. The move follows a company announcement that it has completed Parts B and C of its Phase 2 CIRRUS-HCM trial and reported favorable interim safety observations from Part D—an update that several market outlets characterized as a meaningful de-risking moment

24 December 2025

Pharmaceutical Industry·Stock Market

Johnson & Johnson Stock Today: JNJ Holds Near $207 on Dec. 24, 2025 as Talc Verdict, Drug-Price Pressure and Q4 Earnings Take Center Stage

Johnson & Johnson (NYSE: JNJ) is trading through a holiday-shortened Christmas Eve session with investors balancing a familiar mix of defensive appeal and headline risk. On Wednesday, December 24, 2025, J&J shares hovered around $207 in late-morning trade, keeping the healthcare bellwether close to its recent highs even as the company faces fresh legal scrutiny and renewed policy pressure on U.S. drug pricing. StockAnalysis The immediate backdrop matters: U.S. markets are closing early at 1 p.m. ET for Christmas Eve, a schedule that can amplify moves and distort volume signals—especially for mega-caps like J&J that often act as “parking spots”

24 December 2025

Earnings Reports·NYSE:JNJ·Pharmaceuticals·Stock Market

Previous 1 … 1,061 1,062 1,063 1,064 1,065 … 1,946 Next

IRS tax refund delays? Watchdog flags staffing crunch as 2026 filing season ramps up

7 February 2026

IRS staffing has dropped to 2021 levels as the 2026 tax filing season begins, according to a Treasury watchdog. The agency faces a backlog of about 2 million returns, 129% above pre-pandemic levels. Most e-filers using direct deposit still get refunds within 21 days, but paper filings and amended returns could see delays. The IRS lowered its call-answer target to 70% for this season.

Plug Power stock jumps 12% after vote setback, with Feb 17 share decision in focus

7 February 2026

Plug Power shares rose 11.6% Friday to $2.08 after a sharp drop the previous day, as attention shifted to a Feb. 17 shareholder vote on expanding authorized shares. The company failed to secure enough votes earlier this week and is urging overseas holders to participate. CEO Andy Marsh cited difficulties for European investors in casting ballots. A reverse stock split remains possible if the proposal fails.

Amazon stock slides on $200 billion AI spending plan — what to know before Monday’s open

7 February 2026

Amazon shares fell 5.55% to $210.32 Friday after the company outlined a $200 billion 2026 capex plan and forecast lower-than-expected operating income. D.A. Davidson downgraded the stock, citing tougher cloud competition. Analysts trimmed price targets following the results. Amazon reported Q4 net sales of $213.4 billion and AWS revenue of $35.6 billion.

AT&T stock price: T slips after $6.5B bond sale as payrolls, CPI loom next week

7 February 2026

AT&T shares closed down 0.7% at $27.13 on Friday, underperforming the S&P 500’s 1.97% gain. The company completed a $6.5 billion global notes sale this week, with maturities from 2031 to 2056 and coupons between 4.4% and 6%. Investors await delayed U.S. jobs and inflation data, along with T-Mobile’s upcoming earnings update.

Stock Market News 24 December 2025

Stock Market Today